× Close

Uzbekistan

MSF's office in Nukus, Uzbekistan. © Amelia Freelander/MSF
MSF's office in Nukus, Uzbekistan. © Amelia Freelander/MSF

    Tuberculosis (TB) and HIV care continue to be the focus for MSF in Uzbekistan, which is among the 27 countries with the highest rates of multidrug-resistant TB.

    In January, MSF launched its clinical trial TB PRACTECAL in Nukus, Karakalpakstan, and had enrolled 55 patients by the end of 2017. The trial aims to evaluate regimens containing two promising new drugs, bedaquiline and...

    Read full article in the International Activity Report 2017